LSI Industries (LYTS) Form 4: Option Exercises and Weighted Average Sale $23.29
Rhea-AI Filing Summary
James E. Galeese, Executive Vice President and Chief Financial Officer of LSI Industries Inc. (LYTS), reported multiple option exercises and share transactions dated 09/08/2025. The filing shows option exercises that resulted in acquisitions of 32,874 shares at an exercise price of $9.15 and 21,701 shares at $5.92. On the same date the reporting person sold shares in multiple transactions with a reported weighted average sale price of $23.29, and specific sales tied to the exercised lots are noted. The Form 4 lists remaining beneficial ownership and outstanding options across several strike prices with vesting schedules. The filing includes an explanation that the options were exercised for tax and financial planning purposes and that some shares are held in the company’s Non-Qualified Deferred Compensation Plan.
Positive
- Disclosure includes detailed transaction counts and weighted average sale price
- Filing states exercises were for tax and financial planning, adding context
- Some shares are held in the company's Non-Qualified Deferred Compensation Plan
Negative
- Insider sold material shares on 09/08/2025 (reported sales linked to exercised lots)
- Significant share dispositions reduce the reporting person's direct ownership
Insights
TL;DR: Insider exercised options and sold shares; transactions appear routine and linked to tax planning, not an operational signal.
The reporting shows the CFO exercised options (32,874 at $9.15 and 21,701 at $5.92) and concurrent share sales with a weighted average sale price of $23.29. The transactions reduced direct share holdings while leaving multiple option tranches outstanding with varied strikes and vesting. From a financial perspective these are customary liquidity and tax-planning moves by an executive and do not, by themselves, alter company fundamentals. The filing discloses volumes, prices, and that some shares are in the deferred compensation plan, which aids transparency.
TL;DR: Proper Form 4 disclosure of option exercises and sales; documentation appears compliant and includes price-range disclosure.
The Form 4 is signed by an attorney-in-fact and contains specific exercise and sale entries dated 09/08/2025, plus explanatory notes that the sales occurred in multiple transactions and a commitment to provide full pricing if requested. It also notes options vest ratably over three years and previously reported holdings, which supports procedural compliance. No indication of undisclosed related-party issues or deficient disclosure is present in the submitted content.